Aarti Drugs Limited

Aarti Drugs Limited

Aarti Drugs Limited has received a Closure Directions letter from the Gujarat Pollution Control Board (GPCB) under Section 33A of the Water (Prevention and Control of Pollution) Act, 1974, mandating the closure of manufacturing operations at the Company’s plant located at Plot No. DP-94 to DP-96, Saykha Industrial Estate, Dist. Bharuch, Gujarat, effective 15 days from the date of issuance of the letter, alongside other related directions.

Aarti Drugs Limited

Aarti Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities and listing on stock exchanges.

Aarti Drugs Limited

Aarti Drugs Limited's promoter, Harshit M. Savla, has submitted a disclosure under SEBI Takeover Regulations, stating that two promoter group members, Mirik Rajendra Gogri and Renil Rajendra Gogri, have encumbered 6,41,814 and 5,97,957 shares respectively as of March 31, 2026.

Aarti Drugs Limited

Aarti Drugs Limited has disclosed under SEBI Takeover Regulations that Shri Mirik Rajendra Gogri and Shri Renil Rajendra Gogri, Members of the Promoter Group, have encumbered 6,41,814 and 5,97,957 shares respectively as on March 31, 2026. No other encumbrance has been made by the Promoters/Promoter Group Members during the Financial Year ended March 31, 2026.

Aarti Drugs Limited

Aarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, from July 1, 2026, until the expiry of 48 hours after the declaration of Financial Results for the Quarter ended June 30, 2026.